These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28337871)

  • 41. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
    Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.
    Malur A; Mccoy AJ; Arce S; Barna BP; Kavuru MS; Malur AG; Thomassen MJ
    J Immunol; 2009 May; 182(9):5816-22. PubMed ID: 19380830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppressive effect of anti-alpha 1-antichymotrypsin serum on pulmonary fibrosis induced by phorbol myristate acetate in vivo.
    Nagareda T; Tanaka A; Terada N; Imakon Y; Shiomi H; Matsubara H; Noro A; Nishizawa Y
    Lab Invest; 1995 Oct; 73(4):541-6. PubMed ID: 7474926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma.
    John M; Lim S; Seybold J; Jose P; Robichaud A; O'Connor B; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1998 Jan; 157(1):256-62. PubMed ID: 9445307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current and future treatment options in idiopathic pulmonary fibrosis.
    Hauber HP; Blaukovitsch M
    Inflamm Allergy Drug Targets; 2010 Jul; 9(3):158-72. PubMed ID: 20518722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accumulation of damaged mitochondria in alveolar macrophages with reduced OXPHOS related gene expression in IPF.
    Tsitoura E; Vasarmidi E; Bibaki E; Trachalaki A; Koutoulaki C; Papastratigakis G; Papadogiorgaki S; Chalepakis G; Tzanakis N; Antoniou KM
    Respir Res; 2019 Nov; 20(1):264. PubMed ID: 31775876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
    Serrano-Mollar A; Closa D; Prats N; Blesa S; Martinez-Losa M; Cortijo J; Estrela JM; Morcillo EJ; Bulbena O
    Br J Pharmacol; 2003 Mar; 138(6):1037-48. PubMed ID: 12684259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
    Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W
    Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?
    Prasse A; Müller KM; Kurz C; Hamm H; Virchow JC
    Eur Respir J; 2003 Dec; 22(6):906-11. PubMed ID: 14680077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.
    Antoniou KM; Nicholson AG; Dimadi M; Malagari K; Latsi P; Rapti A; Tzanakis N; Trigidou R; Polychronopoulos V; Bouros D
    Eur Respir J; 2006 Sep; 28(3):496-504. PubMed ID: 16611657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
    Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
    Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pulmonary fibrosis--a therapeutic dilemma?].
    Günther A; Markart P; Eickelberg O; Seeger W
    Med Klin (Munich); 2006 Apr; 101(4):308-12. PubMed ID: 16607487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma).
    Barna BP; Culver DA; Abraham S; Malur A; Bonfield TL; John N; Farver CF; Drazba JA; Raychaudhuri B; Kavuru MS; Thomassen MJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Jun; 23(2):93-100. PubMed ID: 17937104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?
    Hashemi Sadraei N; Riahi T; Masjedi MR
    Arch Iran Med; 2013 Mar; 16(3):177-81. PubMed ID: 23432171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.
    Markart P; Nass R; Ruppert C; Hundack L; Wygrecka M; Korfei M; Boedeker RH; Staehler G; Kroll H; Scheuch G; Seeger W; Guenther A
    J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):161-72. PubMed ID: 20109123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Mathematical Model of Idiopathic Pulmonary Fibrosis.
    Hao W; Marsh C; Friedman A
    PLoS One; 2015; 10(9):e0135097. PubMed ID: 26348490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoengineered immunosuppressive therapeutics modulating M1/M2 macrophages into the balanced status for enhanced idiopathic pulmonary fibrosis therapy.
    Chang X; Xing L; Wang Y; Zhou TJ; Shen LJ; Jiang HL
    Nanoscale; 2020 Apr; 12(16):8664-8678. PubMed ID: 32227023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia.
    Ishii H; Mukae H; Kadota J; Fujii T; Abe K; Ashitani J; Kohno S
    Respiration; 2005; 72(1):39-45. PubMed ID: 15753633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis.
    Ando M; Miyazaki E; Ishii T; Mukai Y; Yamasue M; Fujisaki H; Ito T; Nureki S; Kumamoto T
    Respir Med; 2013 Apr; 107(4):608-15. PubMed ID: 23434037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.